Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-GPCR-Free Fatty Acid Receptor (FFAR)-GPR40 agonist K-757
GPR40 agonist K-757

Chemical Structure : GPR40 agonist K-757

CAS No.: 2696409-13-7

GPR40 agonist K-757

Catalog No.: PC-25130Not For Human Use, Lab Use Only.

GPR40 agonist K-757 is a potent, selective GPR40 (FFA1) agonist with EC50 of 2.1 nM (hGPR40).

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
200 mg Get quote

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

GPR40 agonist K-757 is a potent, selective GPR40 (FFA1) agonist with EC50 of 2.1 nM (hGPR40).
K-757 is selective against panel of 80 enzymes, receptors, and ion channels.
K-757 (10 mg/kg) elicited GLP-1 secretion in crypt cultures derived from wild-type mice but not from GPR40 knockout mice, induced secretion of both GLP-1 and PYY in human crypts.

Physicochemical Properties

M.Wt 541.71
Formula C32H48NO4P
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

((S)-2-Cyclopropyl-2-(3-((1-(2-(4,4-dimethylpentyl)-5-methoxyphenyl)piperidin-4-yl)methoxy)phenyl)ethyl)(methyl)phosphinic Acid

References

1. Moyes CR, et al. J Med Chem. 2025 Jul 24. doi: 10.1021/acs.jmedchem.5c01030.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: